C
ChronicleBio integrates data and biology to uncover insights within complex chronic diseases. The company is building a large-scale living data ecosystem specifically designed to power AI-driven therapeutic discovery. This platform aims to accelerate breakthroughs and improve treatments for debilitating chronic conditions.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- ChronicleBio operates a decentralized research ecosystem that generates and harmonizes multimodal patient data, including deep clinical, molecular, and real-time phenotype information. This adaptive, AI-ready data lake powers advanced disease modeling for complex neuroimmune conditions. The platform delivers actionable insights supporting biomarker discovery, patient stratification, and therapeutic development.